KYNB · Kyntra Bio, Inc

Acquired Company

AstraZeneca completed the acquisition of FibroGen International (Hong Kong) Limited (FibroGen China) and its subsidiaries on 8/29/2025 for approximately $220 million.

Market Cap

N/A

52 Wk Range

N/A - N/A

Previous Close

$6.50

Open

$6.60

Volume

26,079

Day Range

$6.30 - $6.64

Enterprise Value

N/A

Cash

N/A

Avg Qtr Burn

N/A

Insider Ownership

N/A

Institutional Own.

N/A

Qtr Updated

N/A